IDEXX Laboratories Liabilities 2024

IDEXX Laboratories Aktienanalyse

What does IDEXX Laboratories do?

The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

IDEXX Laboratories revenue by segment

In the annual report of the IDEXX Laboratories share (US45168D1046, 888210, IDXX), it breaks down its revenues into 4 segments: 1. Companion Animal Group, 2. Water, 3. Livestock, Poultry & Dairy, 4. Other. The IDEXX Laboratories stock (WKN: 888210, ISIN: US45168D1046, Ticker Symbol: IDXX) is a leading investment for investors interested in participating in the Health Care sector.

88 % Companion Animal Group
6 % Water
5 % Livestock, Poultry & Dairy
1 % Other

Liabilities Details

Assessing IDEXX Laboratories's Liabilities

IDEXX Laboratories's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating IDEXX Laboratories's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing IDEXX Laboratories's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

IDEXX Laboratories's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in IDEXX Laboratories’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about IDEXX Laboratories stock

What is the level of liabilities of IDEXX Laboratories this year?

IDEXX Laboratories has a debt balance of 1.78 B USD this year.

What were the liabilities of IDEXX Laboratories compared to the previous year?

The liabilities of IDEXX Laboratories have increased by -16.96% dropped compared to the previous year.

What are the consequences of high debt for investors of IDEXX Laboratories?

High liabilities can pose a risk for investors of IDEXX Laboratories, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in IDEXX Laboratories?

Low liabilities mean that IDEXX Laboratories has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of IDEXX Laboratories affect the company?

An increase in liabilities of IDEXX Laboratories can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of IDEXX Laboratories affect the company?

A decrease in the liabilities of IDEXX Laboratories can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of IDEXX Laboratories?

Some factors that can influence the liabilities of IDEXX Laboratories include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of IDEXX Laboratories so important for investors?

The liabilities of IDEXX Laboratories are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can IDEXX Laboratories take to modify the liabilities?

To change its liabilities, IDEXX Laboratories can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does IDEXX Laboratories pay?

Over the past 12 months, IDEXX Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEXX Laboratories is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEXX Laboratories?

The current dividend yield of IDEXX Laboratories is .

When does IDEXX Laboratories pay dividends?

IDEXX Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEXX Laboratories?

IDEXX Laboratories paid dividends every year for the past 0 years.

What is the dividend of IDEXX Laboratories?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEXX Laboratories located?

IDEXX Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEXX Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEXX Laboratories from 10/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/27/2024.

When did IDEXX Laboratories pay the last dividend?

The last dividend was paid out on 10/27/2024.

What was the dividend of IDEXX Laboratories in the year 2023?

In the year 2023, IDEXX Laboratories distributed 0 USD as dividends.

In which currency does IDEXX Laboratories pay out the dividend?

The dividends of IDEXX Laboratories are distributed in USD.